Kuehne + Nagel upgrades pharma fleet

Logistics company, Kuehne + Nagel, has deployed 35 new pharma trailers, reinforcing its KN PharmaChain service in Europe.

Before the end of the year, Kuehne + Nagel will add another 45 trailers to the fleet, with a further planned expansion of 200 trailers in the coming years.

By enlarging its own dedicated trailer fleet of standardised Schmitz Cargobull Chassis with Thermo King cooling units (mono, bi-temp and double-deck equipment), Kuehne + Nagel aims at facilitating seamless services for active temperature-controlled FTL and LTL shipments across Europe. The overland pharma fleet is part of the KN PharmaChain network, providing multimodal GxP compliant door-to-door shipping on a global scale, enhanced visibility and traceability of the deliveries, as well as intensive and proactive risk management and integrated warehousing services.

“Logistics solutions for the pharma and healthcare industry are among the most important growth drivers for Kuehne + Nagel’s overland and regional business,” said Senior Vice President Overland Europe at Kuehne + Nagel, Uwe Hött. “This investment is part of our commitment to provide comprehensive, GxP compliant transport solutions for the industry, which can be tailored to specific needs. The continuous upgrades of our equipment and facilities as well as the ongoing training of our dedicated pharma logistics experts are the centrepieces of our KN PharmaChain overland solutions.“

The new pharma trailers are fully GxP compliant and offer state-of-the-art technology for temperature controlled transports, including dual temperature, double-deck equipment, TAPA (Transport Asset Protection Association) compliant integrated security locks to be opened remotely with a unique code, integrated control panel, printer for temperature report and GPS control for positioning, temperature, door sensors, coupling and technical status.

In related news, Kuehne + Nagel aims to establish an integrated region in Europe as of 1 January 2019.

Leave a Reply

JOIN OUR NEWSLETTER
Close